Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study

- Kreiter, Daniel, Kalincik, Tomas, Lechner-Scott, Jeannette, Ozakbas, Serkan, Gerlach, Ozakbas, Turkoglu, R., Soysal, A., Boz, C., Al-Asmi, A., Alkhaboori, J., Amato, M. P., Onofrj, M., Hupperts, Raymond, Lugaresi, A., Besora, S, Sanchez-Menoyo, JL, Lapointe, E, Grand’Maison, F, Grammond, P, Butzkueven, H, Van der Walt, A, Taylor, BV, McCombe, PA, Patti, Francesco, Garber, JY, Skibina, OG, Buzzard, KA, John, NA, Shaw, C, Barnett, MH, Spitaleri, Daniele, Foschi, Matteo, Surcinelli, Andrea, Maimone, Davide, Yamout, Bassem, Khoury, Samia J.

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

- Lorscheider, J., Kuhle, J., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo-Tello, C., Lechner-Scott, J., Pucci, E., Solaro, C., Slee, M., Izquierdo, G., Van Pesch, V., Sanchez Menoyo, J. L., van der Walt, A., Butzkueven, H., Kappos, L., Kalincik, T., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A.

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

- Spelman, T., Mekhael, L., Grammond, P., Barnett, M., Lechner-Scott, J., Alroughani, R., Trojano, M., Lugaresi, A., Granella, F., Pucci, E., Vucic, S., Burke, T., Butzkueven, H., Hodgkinson, S., Havrdova, E., Horakova, D., Duquette, P., Izquierdo, G., Grand'Maison, F.

BREMSO: a simple score to predict early the natural course of multiple sclerosis

- Bergamaschi, R., Montomoli, C., Boz, C., Iuliano, G., Zwanikken, C., Petersen, T., Lechner-Scott, J., Hupperts, R., Butzkueven, H., Pucci, E., Oreja-Guevara, C., Cristiano, E., Mallucci, G., Pia Amato, M. P., Havrdova, E., Fernandez-Bolanos, R., Spelman, T., Trojano, M., Lugaresi, A., Izquierdo, G., Grand'Maison, F., Duquette, P., Shaygannejad, V., Alroughani, R., Grammond, P.